CCR3-active chemokines promote rapid detachment of eosinophils from VCAM-1 in vitro.
Selective eosinophil recruitment is the result of orchestrated events involving cell adhesion molecules, chemokines, and their receptors. The mechanisms by which chemokines regulate eosinophil adhesion and migration via integrins are not fully understood. In our study, we examined the effect of CCR3-active chemokines on eosinophil adhesion to VCAM-1 and BSA under both static and flow conditions. When eotaxin-2 or other CCR3-active chemokines were added to adherent eosinophils, it induced rapid and sustained eosinophil detachment from VCAM-1 in a concentration-dependent manner. Adhesion was detectably reduced within 3 min and was further reduced at 10-60 min. Simultaneously, eotaxin-2 enhanced eosinophil adhesion to BSA. Preincubation of eosinophils with the CCR3-blocking mAb 7B11 completely prevented chemokine-induced changes in adhesion to VCAM-1 and BSA. Using a different protocol, pretreatment of eosinophils with chemokines for 0-30 min before their use in adhesion assays resulted in inhibition of VCAM-1 adhesion and enhancement of BSA adhesion. By flow cytometry, expression of alpha4 integrins and a beta1 integrin activation epitope on eosinophils was decreased by eotaxin-2. In a flow-based adhesion assay, eotaxin-2 reduced eosinophil accumulation and the strength of attachment to VCAM-1. These results show that eotaxin-2 rapidly reduced alpha4 integrin function while increasing beta2 integrin function. These findings suggest that chemokines facilitate migration of eosinophils by shifting usage away from beta1 integrins toward beta2 integrins.
Tachimoto
H
H
Department of Medicine, Division of Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA.
Burdick
M M
MM
Hudson
S A
SA
Kikuchi
M
M
Konstantopoulos
K
K
Bochner
B S
BS
D000199:Actins / Q000502:physiology; D019138:Antibodies, Blocking / Q000494:pharmacology; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D002448:Cell Adhesion / Q000276:immunology*; D002462:Cell Membrane / Q000276:immunology / Q000378:metabolism; D002465:Cell Movement / Q000276:immunology; D002469:Cell Separation; D054423:Chemokine CCL24; D019742:Chemokines, CC / Q000502:physiology; D004804:Eosinophils / Q000276:immunology* / Q000378:metabolism / Q000502:physiology; D005434:Flow Cytometry; D006801:Humans; D016023:Integrins / Q000037:antagonists & inhibitors / Q000276:immunology / Q000378:metabolism; D008870:Microtubules / Q000502:physiology; D054397:Receptors, CCR3; D019707:Receptors, Chemokine / Q000502:physiology*; D012212:Rheology; D012710:Serum Albumin, Bovine / Q000378:metabolism / Q000502:physiology; D013314:Stress, Mechanical; D019010:Vascular Cell Adhesion Molecule-1 / Q000378:metabolism*
D000199:Actins; D019138:Antibodies, Blocking; D000911:Antibodies, Monoclonal; C515484:CCL24 protein, human; C515350:CCR3 protein, human; D054423:Chemokine CCL24; D019742:Chemokines, CC; D016023:Integrins; D054397:Receptors, CCR3; D019707:Receptors, Chemokine; D019010:Vascular Cell Adhesion Molecule-1; D012710:Serum Albumin, Bovine